D'ANGELO, SERGIO
 Distribuzione geografica
Continente #
EU - Europa 66
AS - Asia 43
NA - Nord America 33
SA - Sud America 13
AF - Africa 1
Totale 156
Nazione #
US - Stati Uniti d'America 32
IE - Irlanda 30
SG - Singapore 19
SE - Svezia 14
BR - Brasile 11
CN - Cina 10
HK - Hong Kong 6
RU - Federazione Russa 5
VN - Vietnam 5
FI - Finlandia 4
DE - Germania 3
BD - Bangladesh 2
FR - Francia 2
UA - Ucraina 2
CZ - Repubblica Ceca 1
EC - Ecuador 1
GB - Regno Unito 1
HN - Honduras 1
IN - India 1
IT - Italia 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
PY - Paraguay 1
ZA - Sudafrica 1
Totale 156
Città #
Dublin 30
Singapore 11
Nyköping 10
Hong Kong 6
Ashburn 5
Beijing 4
Helsinki 4
Los Angeles 3
Moscow 3
Santa Clara 3
Guangzhou 2
Ho Chi Minh City 2
Munich 2
Paris 2
Princeton 2
Wilmington 2
Amparo 1
Andradina 1
Asunción 1
Betim 1
Boston 1
Brno 1
Brooklyn 1
Buon Ma Thuot 1
Cascavel 1
Chicago 1
Chisinau 1
Colniza 1
Delhi 1
Dom Pedro 1
El Progreso 1
Falkenstein 1
Guayaquil 1
Jacksonville 1
London 1
Luxembourg 1
Midrand 1
Norfolk 1
Nova Friburgo 1
Orem 1
Piracicaba 1
Regente Feijó 1
Ribeirão Preto 1
Shanghai 1
Sóc Trăng 1
Thái Nguyên 1
Triggiano 1
Urânia 1
Wuhan 1
Totale 124
Nome #
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 70
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 50
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 46
Totale 166
Categoria #
all - tutte 1.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 1 2 0 2 1 0 0
2021/202216 0 3 1 0 1 0 0 1 2 5 0 3
2022/202348 6 1 1 3 0 2 0 5 30 0 0 0
2023/202412 1 2 1 2 1 1 0 0 0 0 0 4
2024/202547 3 1 1 2 1 12 0 6 7 3 8 3
2025/202637 10 7 8 7 5 0 0 0 0 0 0 0
Totale 166